Jump to content

Clara D. Bloomfield

From Wikipedia, the free encyclopedia
Clara Derber Bloomfield
Born(1942-05-15)May 15, 1942
Flushing, New York
DiedMarch 1, 2020(2020-03-01) (aged 77)
Columbus, Ohio
Occupation(s)Physician, scientist
SpouseAlbert de la Chapelle (c. 1984–2020; her death)

Clara Derber Bloomfield (May 15, 1942 – March 1, 2020), was an American physician and cancer researcher. Her work focused on the genetic changes that are present in certain types of blood cancers, and how those can be utilized to improve treatment for the affected patients.

Education

[edit]

Clara D. Bloomfield graduated from University Laboratory High School in 1959,[1] earned her B.A. from the San Diego State College (San Diego, California) in 1963, and earned her M.D. from the University of Chicago in 1968.[2] She completed a residency in internal medicine at the University of Chicago and a fellowship in medical oncology at the University of Minnesota.[2]

Career

[edit]

Bloomfield was the first woman to reach the rank of a full professor of medicine at the University of Minnesota in 1980. In 1989, she became professor of medicine and chief of the Division of Oncology at the State University of New York at Buffalo.[2] At the same time, she was chair of the Division of Medicine at Roswell Park Comprehensive Cancer Center.[2]

In 1997, she moved to Columbus, Ohio, where she became director of the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).[2] She held this position until 2003.[2]

Bloomfield was a distinguished university professor and senior adviser at the OSUCCC-James.[2] She was also a member of the Molecular Biology and Cancer Genetics Program, a professor of internal medicine, and she held the William Greenville Pace III Endowed Chair in Cancer Research.[citation needed]

Research

[edit]

Early in her career, Bloomfield focused on the study of chromosome abnormalities in cancers of the hematopoietic system (leukemias and lymphomas). She and her co-workers identified several novel chromosome changes in leukemia and lymphoma, and discovered that these abnormalities are among the most important factors that determine a patient's prognosis. For example, Bloomfield was involved in the discovery of the Philadelphia chromosome in patients with acute lymphoblastic leukemia (ALL).[3] She was also involved in describing the rearrangement of chromosome 16q22 in acute myeloid leukemia.

Bloomfield co-authored the World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues,[4] and the European LeukemiaNet (ELN) guidelines on diagnosis and management of acute myeloid leukemia.[5]

Personal life

[edit]

In 1984, Bloomfield was married to Albert de la Chapelle,[6] a geneticist and professor in the Department of Molecular Virology, Immunology and Medical Genetics at Ohio State University and discoverer of XX male syndrome.

Death

[edit]

Bloomfield died on March 1, 2020, aged 77, after an accident[7] in Columbus, Ohio.[8]

Honors and awards

[edit]

Bloomfield was elected a member of the Institute of Medicine of the National Academy of Sciences in 2000. In 2011, she was elected as a fellow of the American Academy of Arts and Sciences. She also was an elected member of the Association of American Physicians and an elected fellow of the American Association for the Advancement of Science.[citation needed]

Among the awards Bloomfield received during her career are:

Sources

[edit]

References

[edit]
  1. ^ "Dr. Clara Derber Bloomfield - Class of 1959 | University Laboratory High School | UIUC". www.uni.illinois.edu. Retrieved 2023-01-22.
  2. ^ a b c d e f g Piana, Ronald (2 December 2008). "Clara Bloomfield: Buck conventional wisdom always". Archived from the original on 20 December 2018. Retrieved 20 December 2018.
  3. ^ Bloomfield, CD; Peterson, LC; Yunis, JJ; Brunning, RD (1977). "The Philadelphia chromosome (Ph1) in adults presenting with acute leukaemia: A comparison of Ph1+ and Ph1-patients". British Journal of Haematology. 36 (3): 347–58. doi:10.1111/j.1365-2141.1977.tb00658.x. PMID 268208. S2CID 33472110.
  4. ^ The International Agency for Research on Cancer (2008). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th ed.). World Health Organization. p. 441. ISBN 978-92-832-2431-0.
  5. ^ Dohner, H.; Estey, E. H.; Amadori, S.; Appelbaum, F. R.; Buchner, T.; Burnett, A. K.; Dombret, H.; Fenaux, P.; et al. (2009). "Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet". Blood. 115 (3): 453–74. doi:10.1182/blood-2009-07-235358. PMID 19880497.
  6. ^ Paavilainen, Ulla, ed. (2014). Kuka kukin on: Henkilötietoja nykypolven suomalaisista 2015 [Who’s Who in Finland, 2015] (in Finnish). Helsinki: Otava. p. 84. ISBN 978-951-1-28228-0.
  7. ^ Kere, Juha & Lehesjoki, Anna-Elina (3 January 2021). "Huikea kansainvälinen ura". Helsingin Sanomat (in Finnish). Helsinki. p. C 17.{{cite news}}: CS1 maint: multiple names: authors list (link)
  8. ^ "Ohio State announces passing of leukemia scientist Clara Bloomfield". Ohio State University. March 3, 2020. Retrieved March 18, 2020.
  9. ^ "AACR Joseph H. Burchenal Clinical Research Award Winners". Archived from the original on April 27, 2012.
  10. ^ "ASH Awards". www.hematology.org.
  11. ^ "Making Strides toward "Curing the Incurable": Karnofsky Award Winner, Dr. Clara Bloomfield, Honored for Practice-changing Leukemia, Lymphoma Research". Archived from the original on 2012-04-05. Retrieved 2011-11-23.
  12. ^ "Clara D. Bloomfield, MD | Giants of Cancer Care". www.giantsofcancercare.com.
  13. ^ "Margaret Kripke Legend Award Recipients.docx" (PDF). Retrieved 2020-03-18.
[edit]
Scholia has an author profile for Clara D. Bloomfield.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Clara_D._Bloomfield&oldid=1217698563"